VTRS · 10-Q · 2026Q3 · Full report
Headcount / Restructuring
Viatris Inc · 2026-11-05 · Importance 46 · Surprise 42 · In source text
Viatris began implementing restructuring activities following its enterprise-wide strategic review, announced February 26, 2026, to optimize commercial capabilities, enabling functions, R&D, medical affairs, regulatory activities, sourcing, manufacturing and supply chain operations. The program anticipates a global workforce reduction of up to approximately 10%, with activities and associated costs and savings expected to be completed primarily over the three years ending 2028. The company expects total pre-tax charges of $700 million to $850 million, including $650 million to $750 million in cash costs and $50 million to $100 million in non-cash charges. Management estimates fully implemented savings of $600 million to $700 million, most of which are expected to improve operating cash flow.
Key facts
- Viatris expects savings of $600 million to $700 million from committed restructuring activities once fully implemented, with most savings expected to improve operating cash flow. source
- Viatris expects total pretax charges of $700 million to $850 million for committed EWSR restructuring activities, including $50 million to $100 million of non-cash charges. source
- Viatris estimates cash restructuring costs of $650 million to $750 million, primarily for severance and employee benefits, contract terminations, vendor consolidations, product transfer costs, and network simplification and modernization. source
- Viatris' restructuring costs for the nine months ended September 30, 2026 included $95.8 million in cost of sales, $3.4 million in R&D and $107.3 million in SG&A, primarily related to the 2026 restructuring program. source
- Viatris expects its 2026 restructuring activities and associated costs and savings to be completed primarily over the three years ending 2028, with a global workforce reduction of up to approximately 10%. source
- Viatris recognized restructuring charges of $52.1 million for the three months and $157.3 million for the nine months ended September 30, 2026. source
- Viatris’s third-quarter 2026 SG&A expense increased $64.2 million to $950.8 million, primarily due to approximately $42.6 million of higher restructuring costs related mainly to the EWSR. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | committed | -17.6% | Viatris expects total pretax charges of $700 million to $850 million for committed EWSR restructuring activities, including $50 million to… |
| operating_income | positive | committed | +14.8% | Viatris expects savings of $600 million to $700 million from committed restructuring activities once fully implemented, with most savings… |
| operating_income | negative | realized | -5.5% | Viatris' restructuring costs for the nine months ended September 30, 2026 included $95.8 million in cost of sales, $3.4 million in R&D and… |
| cash | negative | committed | -1.7% | Viatris estimates cash restructuring costs of $650 million to $750 million, primarily for severance and employee benefits, contract… |
| cash | positive | committed | — | Viatris expects savings of $600 million to $700 million from committed restructuring activities once fully implemented, with most savings… |